To Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions
Clinical trial NCT03743259 · COMPLETED
Trial details
- NCT number
- NCT03743259
- Sponsor
- Hanlim Pharm. Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-29
- Primary completion
- 2019-01-11
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.